In this 23-second video clip, Peter Aaby, DMSc, founder of the Bandim Health Project in West Africa, notes that they found that a new measles vaccine that was recommended by the WHO in 1989 increased the death rate in female infants 2-fold.

He notes that, had it been implemented, the new measles vaccine would have caused an additional 500,000 female deaths in Africa.

Peter Aaby is credited for the discovery of non-specific effects of vaccines – i.e. effects of vaccines, which go beyond the specific protective effects against the targeted diseases.

Infants 3 to 5 months old were 5-times more likely to die if they had received both the Diphtheria-Tetanus-Pertussis (DTP) vaccine and the Oral Polio Vaccine (OPV) than infants of the same age who had not been vaccinated according to a 2017 study of an urban African community by Danish researchers.

Infants 3 to 5 months old were 10-times more likely to die if they had received only the Diphtheria-Tetanus-Pertussis (DTP) vaccine, and not the Oral Polio Vaccine.

(In other words, giving the oral polio vaccine along with the DTP vaccine seemed to reduce the negative effects of the DTP vaccine.)

“All currently available evidence suggests that DTP vaccine may kill more children from other causes than it saves from diphtheria, tetanus or pertussis,” the authors of the study concluded.

When a cell phone is held next to the body, such as held next to the head or in a pocket or in a bra, people are exposed to up to 9 times more radiation than current US guidelines allow according to recent test data from the French national radiation testing agency as noted by toxicologist and epidemiologist, Devra Davis PhD, MPH, President and Founder of Environmental Health Trust.

Davis also notes that it has been known for ten years that men who carry their cell phone in their pocket have lower sperm counts and lower sperm qualitys.

The study found that people with low cholesterol levels — below 200 mg/dL — who had an ischemic stroke were 88% more likely to die over the next 5 years compared with people who had higher cholesterol levels — above 200 mg/dL.

To say this the other way, people who had an ischemic stroke who had higher cholesterol levels — above 200 mg/dL — were 47% less likely to die over the next 5 years than people with lower cholesterol levels — below 200 mg/dL.

Why would you ever give a statin or any other cholesterol-lowering drug to anyone who has had a stroke after seeing the results of this study?

Good adherence to taking a cholesterol-lowering drug known as clofibrate was associated with a 39% lower mortality compared to those with poor adherence to taking clofibrate (15% mortality vs 24.6% mortality) according to a 1980 study, however the same thing was true for placebo; those with good adherence to taking placebo was associated with a 47% lower mortality compared to those with poor adherence to taking placebo (15.1% mortality vs 28.3% mortality).